Svetol cuts BMI and boosts lean mass

12 March 2007

Berkem, a French polyphenols specialist, says that a recent study published in the February edition of the journal Phytotherapie shows that its decaffeinated green coffee bean extract, Svetol, reduced body mass index and increased lean mass to fat mass ratio. In the placebo-controlled, double-blind, clinical study a total of 50 participants were enrolled, aged between 19 and 75 years, with a BMI greater than 25. As part of the evaluation, 30 patients were administered a 200mg capsule of Svetol twice a day, while the others received a placebo. After 60 days of treatment, researchers observed a statistically-significant mean reduction in weight of 5.7% (average reduction of 5kg) and an increase in the lean to fat mass ratio of 4%, as compared to only 2.9% and 1.5%, respectively in the placebo group.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight